ChiCTR2000033463 版本V1.1 版本创建时间2020/06/01 15:47:01 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000033463 

最近更新日期:

Date of Last Refreshed on:

2020-06-01 15:46:32 

注册时间:

Date of Registration:

1990-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

待编辑(一)生活方式对早泄及勃起功能的影响

Public title:

The Impact of life style on premature ejaculation and erectile function

注册题目简写:

English Acronym:

研究课题的正式科学名称:

生活方式对早泄及勃起功能的影响

Scientific title:

The Impact of life style on premature ejaculation and erectile function

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

白松 

研究负责人:

白松 

Applicant:

Song Bai 

Study leader:

Song Bai 

申请注册联系人电话:

Applicant telephone:

+86 18940255568

研究负责人电话:

Study leader's
telephone:

+86 18940255568

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

baisongcmu@163.com

研究负责人电子邮件:

Study leader's E-mail:

baisongcmu@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国辽宁沈阳市和平区三好街36号

研究负责人通讯地址:

中国辽宁沈阳市和平区三好街36号

Applicant address:

36 Sanhao Street, Shenyang, Liaoning, China

Study leader's address:

36 Sanhao Street, Shenyang, Liaoning, China

申请注册联系人邮政编码:

Applicant postcode:

110004

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国医科大学附属盛京医院 泌尿外科

Applicant's institution:

Department of Urology, ShengJing Hospital of China Medical University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019PS650K

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国医科大学附属盛京医院伦理委员会批准

Name of the ethic committee:

The ethics committee of Shengjing Hospital of China Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

赵玉虹

Contact Name of the ethic committee:

Yuhong Zhao

伦理委员会联系地址:

中国医科大学附属盛京医院 伦理委员会 沈阳市和平区三好街36号,邮编110004

Contact Address of the ethic committee:

Department of ethics committee, ShengJing Hospital of China Medical University, 36 Sanhao Street, Shenyang, Liaoning, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国医科大学附属盛京医院 泌尿外科

Primary sponsor:

Department of Urology, ShengJing Hospital of China Medical University

研究实施负责(组长)单位地址:

中国辽宁沈阳市和平区三好街36号

Primary sponsor's address:

36 Sanhao Street, Shenyang, Liaoning, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

辽宁

市(区县):

沈阳

Country:

China

Province:

Liaoning

City:

Shenyang

单位(医院):

中国医科大学附属盛京医院

具体地址:

和平区三好街36号

Institution
hospital:

Shengjing Hospital of China Medical University

Address:

36 Sanhao Street, Heping District

经费或物资来源:

辽宁省教育厅自然科学基金 (QN2019013);辽宁省科技厅自然科学基金 (2020-BS-093)

Source(s) of funding:

The Natural Science Foundation of Liaoning province educational program (grant number: QN2019013);The Natural Science Foundation of Liaoning province technological program (grant number: 2020-BS-093).

研究疾病:

勃起功能障碍和早泄  

Target disease:

erectile dysfunction and premature ejaculation

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

巢式病例-对照研究 

Study design:

Nested case-control study 

研究目的:

本研究旨在探讨生活方式对早泄及勃起功能的影响  

Objectives of Study:

The aim of the present study is to determine the contribution of life style on premature ejaculation and erectile function

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

年龄在18岁以上、与同一伴侣保持稳定、一夫一妻、异性恋关系至少6个月的男性有资格参加这项研究。此外,由于在研究中使用了口头问卷,受试者必须能够理解和说汉语。

Inclusion criteria

Men aged over 18 years who had been in a stable, monogamous, heterosexual relationship with the same partner for at least 6 months were eligible for the study. In addition, because a verbal questionnaire was used in the study, subjects had to be able to comprehend and speak Chinese.

排除标准:

排除服用可能影响射精和勃起功能和/或心理状态的药物的男性(如选择性5-羟色胺再摄取抑制剂和磷酸二酯酶5型抑制剂)。

Exclusion criteria:

Men on medication that could have affected their ejaculatory and erectile function and/or psychological status were excluded (e.g., selective serotonin reuptake inhibitors and phosphodiesterase type 5 inhibitors).

研究实施时间:

Study execute time:

From 2020-06-08 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-08 00:00:00 To 2020-12-30 00:00:00

干预措施:

Interventions:

组别:

早泄或勃起功能障碍组

样本量:

300

Group:

premature ejaculation or erectile dysfunction group

Sample size:

干预措施:

干预措施代码:

Intervention:

not applicable

Intervention code:

组别:

健康组

样本量:

300

Group:

Healthy group

Sample size:

干预措施:

干预措施代码:

Intervention:

not applicable

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

辽宁 

市(区县):

沈阳 

Country:

China

Province:

Liaoning

City:

Shenyang

单位(医院):

中国医科大学附属盛京医院 

单位级别:

三甲 

Institution
hospital:

Shengjing Hospital of China Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

IIEF5 和 PEDT

指标类型:

主要指标

Outcome:

IIEF5 and PEDT

Type:

Primary indicator

测量时间点:

1 月后

测量方法:

问卷

Measure time point of outcome:

after one month

Measure method:

queationaire

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

不适用

Randomization Procedure (please state who generates the random number sequence and by what method):

not applicable

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Private

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

不公开

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Private

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-06-01 15:46:13